Načítá se...
Promising therapies for treatment of nonalcoholic steatohepatitis
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) has become the most common etiology for abnormal aminotransferase levels and chronic liver disease. Its growing prevalence is largely linked to the presence of metabolic syndrome, particularly diabetes and insulin resistance. It is estimated th...
Uloženo v:
| Vydáno v: | Expert Opin Emerg Drugs |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906104/ https://ncbi.nlm.nih.gov/pubmed/27501374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2016.1220533 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|